179 related articles for article (PubMed ID: 34402453)
1. Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus.
Stefanski AL; Dörner T
Curr Opin Rheumatol; 2021 Nov; 33(6):592-597. PubMed ID: 34402453
[TBL] [Abstract][Full Text] [Related]
2. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production.
Liu Z; Liu S; Zhang Y; Zeng W; Wang S; Ji P; Pan M; Zhu C; Wang Y
Cell Immunol; 2021 Oct; 368():104420. PubMed ID: 34418679
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
Marken J; Muralidharan S; Giltiay NV
Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.
Zhang J; Guo Q; Dai D; Yu J; Wang L; Wu Z; Ding H; Shen N; Duan Y
Biomaterials; 2022 Oct; 289():121766. PubMed ID: 36087549
[TBL] [Abstract][Full Text] [Related]
7. The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus.
Lu KL; Wu MY; Wang CH; Wang CW; Hung SI; Chung WH; Chen CB
Cells; 2019 Oct; 8(10):. PubMed ID: 31597242
[TBL] [Abstract][Full Text] [Related]
8. The immunological basis of B-cell therapy in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
[TBL] [Abstract][Full Text] [Related]
9. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
[TBL] [Abstract][Full Text] [Related]
10. B cell abnormalities in systemic lupus erythematosus.
Grammer AC; Lipsky PE
Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S22-7. PubMed ID: 15180894
[TBL] [Abstract][Full Text] [Related]
11. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
13. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
[TBL] [Abstract][Full Text] [Related]
14. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
[TBL] [Abstract][Full Text] [Related]
17. B cell biology: implications for treatment of systemic lupus erythematosus.
Anolik JH
Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
[TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
19. Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE).
Davidson A; Wang X; Mihara M; Ramanujam M; Huang W; Schiffer L; Sinha J
Ann N Y Acad Sci; 2003 Apr; 987():188-98. PubMed ID: 12727639
[TBL] [Abstract][Full Text] [Related]
20. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
